Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release

Journal of General Virology

Volumn 85, Issue 10, 2004, Pages 2903-2913

  Abdurahman, Samir ^a   Höglund, Stefan ^b   Goobar Larsson, Laura ^a   Vahlne, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CAPSID PROTEIN; GAG PROTEIN; GUANINE; LEUCINE; POL PROTEIN; PROLINE; VALINE; VIRUS PROTEIN; P55 GAG PRECURSOR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN PRECURSOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; DIMERIZATION; GENE SEQUENCE; GENETIC CONSERVATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; VIRUS ASSEMBLY; VIRUS CORE; VIRUS INFECTIVITY; VIRUS MORPHOGENESIS; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RABBIT; STRUCTURE ACTIVITY RELATION; ULTRASTRUCTURE; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CONSERVED SEQUENCE; FLUORESCENT ANTIBODY TECHNIQUE; GENE PRODUCTS, GAG; HIV CORE PROTEIN P24; HIV-1; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRION; VIRUS ASSEMBLY;

EID: 5444255004     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80137-0     Document Type: Article

References (48)

1. Berthet-Colominas, C., Monaco, S., Novelli, A., Sibaï, G., Mallet, F. & Cusack, S. (1999). Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J 18, 1124-1136.
2. Borsetti, A., Öhagen, Å. & Göttlinger, H. G. (1998). The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J Virol 72, 9313-9317.
3. Chen, Y.-L., Ts'ai, P.-W., Yang, C.-C. & Wang, C.-T. (1997). Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants. J Gen Virol 78, 2497-2501.
4. gag-pol into virus particles. J Virol 76, 3221-3231.
5. Dorfman, T., Bukovsky, A., Öhagen, Å., Höglund, S. & Göttlinger, H. G. (1994). Functional domains of the capsid protein of human immunodeficiency virus type 1. J Virol 68, 8180-8187.
6. Forshey, B. M., von Schwedler, U., Sundquist, W. I. & Aiken, C. (2002). Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 76, 5667-5677.
7. Freed, E. O. (1998). HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251, 1-15.
8. Furuta, R. A., Shimano, R., Ogasawara, T., Inubushi, R., Amano, K., Akari, H., Hatanaka, M., Kawamura, M. & Adachi, A. (1997 . HIV-1 capsid mutants inhibit the replication of wild-type virus at both early and late infection phases. FEBS Lett 415, 231-234.
9. Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I. & Hill, C. P. (1996). Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87, 1285-1294.
10. Gamble, T. R., Yoo, S., Vajdos, F. F., von Schwedler, U. K., Worthylake, D. K., Wang, H., McCutcheon, J. P., Sundquist, W. I. & Hill, C. P. (1997). Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278, 849-853.
11. Ganser, B. K., Li, S., Klishko, V. Y., Finch, J. T. & Sundquist, W. I. (1999). Assembly and analysis of conical models for the HIV-1 core. Science 283, 80-83.
12. Gelderblom, H. R., Hausmann, E. H. S., Özel, M., Pauli, G. & Koch, M. A. (1987). Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156, 171-176.
13. Gitti, R. K., Lee, B. M., Walker, J., Summers, M. F., Yoo, S. & Sundquist, W. I. (1996). Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273, 231-235.
14. Göttlinger, H. G., Sodroski, J. G. & Haseltine, W. A. (1989). Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 86, 5781-5785.
15. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A. & Pavlakis, G. N. (1989). The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol 63, 1265-1274.
16. Hinkula, J., Rosen, J., Sundqvist, V.-A., Stigbrand, T. & Wahren, B. (1990). Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol Immunol 27, 395-403.
17. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. & Pease, L. R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
18. Höglund, S., Ofverstedt, L. G., Nilsson, A., Lundquist, P., Gelderblom, H., Ozel, M. & Skoglund, U. (1992). Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retrovir 8, 1-7.
19. Höglund, S., Su, J., Reneby, S. S. & 7 other authors (2002). Tripeptide interference with human immunodeficiency virus type 1 morphogenesis. Antimicrob Agents Chemother 46, 3597-3605.
20. gag-pol into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein. J Virol 71, 4472-4478.
21. Kaplan, A. H. & Swanstrom, R. (1991). Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc Natl Acad Sci U S A 88, 4528-4532.
22. Kaplan, A. H., Manchester, M. & Swanstrom, R. (1994). The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J Virol 68, 6782-6786.
23. Karacostas, V., Wolffe, E. J., Nagashima, K., Gonda, M. A. & Moss, B. (1993). Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193, 661-671.
24. Kattenbeck, B., Rohrhofer, A., Niedrig, M., Wolf, H. & Modrow, S. (1996). Defined amino acids in the gag proteins of human immunodeficiency virus type 1 are functionally active during virus assembly. Intervirology 39, 32-39.
25. Kattenbeck, B., von Poblotzki, A., Rohrhofer, A., Wolf, H. & Modrow, S. (1997). Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein. J Gen Virol 78, 2489-2496.
26. Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M. & Mitrophanous, K. A. (2000). A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 74, 4839-4852.
27. Lee, Y.-M., Tian, C.-J. & Yu, X-F. (1998). A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner. J Virol 72, 9061-9068.
28. Li, S., Hill, C. P., Sundquist, W. I. & Finch, J. T. (2000). Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407, 409-413.
29. Luban, J., Lee, C. & Goff, S. P. (1993). Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. J Virol 67, 3630-3634.
30. Momany, C., Kovari, L. C., Prongay, A. J. & 10 other authors (1996). Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol 3, 763-770.
31. Myers, G., Berzofsky, J. A., Korber, B., Smith, R. F. & Pavlakis, G. N. (1991). Human Retroviruses and AIDS: a Compilation and Analysis of Nucleic and Amino Acid Sequences. Los Alamos, NM: Los Alamos National Laboratory.
32. Ott, D. E. (2002). Potential roles of cellular proteins in HIV-1. Rev Med Virol 12, 359-374.
33. Parker, S. D. & Hunter, E. (2000). A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids. J Virol 74, 784-795.
34. Pettit, S. C., Moody, M. D., Wehbie, R. S., Kaplan, A. H., Nantermet, P. V., Klein, C. A. & Swanstrom, R. (1994). The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol 68, 8017-8027.
35. Sakuragi, J., Sakai, H., Kawamura, M., Tokunaga, K., Ueda, S. & Adachi, A. (1995). Generation and characterization of a host cell-dependent gag gene mutant of human immunodeficiency virus type 1. Virology 212, 251-254.
36. Schneider, R., Campbell, M., Nasioulas, G., Felber, B. K. & Pavlakis, G. N. (1997). Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/Protease and particle formation. J Virol 71, 4892-4903.
37. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1991). Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 183, 677-686.
38. Srinivasakumar, N., Hammarskjöld, M.-L. & Rekosh, D. (1995). Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol 69, 6106-6114.
39. Su, J., Palm, A., Wu, Y., Sandin, S., Höglund, S. & Vahlne, A. (2000). Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells. AIDS Res Hum Retrovir 16, 37-48.
40. Szilvay, A. M., Nornes, S., Haugan, I. R., Olsen, L., Prasad, V. R., Endresen, C., Goff, S. P. & Helland, D. E. (1992). Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase H activities. J Acquir Immune Defic Syndr 5, 647-657.
41. Talbott, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. A. & Elder, J. H. (1989). Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A 86, 5743-5747.
42. Vogt, V. M. (1996). Proteolytic processing and particle maturation. Curr Top Microbiol Immunol 214, 95-131.
43. gag-polyprotein essential for HIV-1 particle formation. Virology 193, 981-985.
44. von Schwedler, U. K., Stray, K. M., Garrus, J. E. & Sundquist, W. I. (2003). Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 77, 5439-5450.
45. Worthylake, D. K., Wang, H., Yoo, S., Sundquist, W. I. & Hill, C. P. (1999). Structures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution. Acta Crystallogr Sect D Biol Crystallogr 55, 85-92.
46. Yoo, S., Myszka, D. G., Yeh, C., McMurray, M., Hill, C. P. & Sundquist, W. I. (1997). Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol Biol 269, 780-795.
47. Yuan, X., Yu, X., Lee, T.-H. & Essex, M. (1993). Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol 67, 6387-6394.
48. Zhang, W.-H., Hockley, D. J., Nermut, M. V., Morikawa, Y. & Jones, I. M. (1996). Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly. J Gen Virol 77, 743-751.